Diabetic nephropathy

Mark E. Molitch; Ralph A. DeFronzo; Marion J. Franz; William F. Keane; Carl Erik Mogensen; Hans Henrik Parving; Michael W. Steffes

doi:10.2337/diacare.25.2007.s85

Diabetic nephropathy

Mark E. Molitch, Ralph A. DeFronzo, Marion J. Franz, William F. Keane, Carl Erik Mogensen, Hans Henrik Parving, Michael W. Steffes

Department of Medicine

Resultado de la investigación: Review article › revisión exhaustiva

209 Citas (Scopus)

Resumen

Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of ACE inhibitors or ARBs will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.

Idioma original	English (US)
Páginas (desde-hasta)	S85-S89
Publicación	Diabetes care
Volumen	25
N.º	SUPPL. 1
DOI	https://doi.org/10.2337/diacare.25.2007.s85
Estado	Published - ene 2002

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Advanced and Specialized Nursing

Acceder al documento

10.2337/diacare.25.2007.s85

Otros archivos y enlaces

Citar esto

@article{26072c99137c4525b227ec07ccf69154,

title = "Diabetic nephropathy",

abstract = "Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of ACE inhibitors or ARBs will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.",

author = "Molitch, {Mark E.} and DeFronzo, {Ralph A.} and Franz, {Marion J.} and Keane, {William F.} and Mogensen, {Carl Erik} and Parving, {Hans Henrik} and Steffes, {Michael W.}",

year = "2002",

month = jan,

doi = "10.2337/diacare.25.2007.s85",

language = "English (US)",

volume = "25",

pages = "S85--S89",

journal = "Diabetes Care",

issn = "1935-5548",

publisher = "American Diabetes Association Inc.",

number = "SUPPL. 1",

}

TY - JOUR

T1 - Diabetic nephropathy

AU - Molitch, Mark E.

AU - DeFronzo, Ralph A.

AU - Franz, Marion J.

AU - Keane, William F.

AU - Mogensen, Carl Erik

AU - Parving, Hans Henrik

AU - Steffes, Michael W.

PY - 2002/1

Y1 - 2002/1

N2 - Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of ACE inhibitors or ARBs will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.

AB - Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of ACE inhibitors or ARBs will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.

UR - http://www.scopus.com/inward/record.url?scp=23944511753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23944511753&partnerID=8YFLogxK

U2 - 10.2337/diacare.25.2007.s85

DO - 10.2337/diacare.25.2007.s85

M3 - Review article

AN - SCOPUS:23944511753

SN - 1935-5548

VL - 25

SP - S85-S89

JO - Diabetes Care

JF - Diabetes Care

IS - SUPPL. 1

ER -

Diabetic nephropathy

Resumen

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto